期刊文献+

人睾丸发生过程中TGF β_1表达的研究 被引量:3

STUDY ON THE EXPRESSION OF TGF β_1 IN TESTES OF HUMAN FETUS
下载PDF
导出
摘要 研究 TGFβ1 (转化生长因子β1 )在人胚胎睾丸发生过程中的表达。收集 30例 12 - 32周龄胎儿睾丸标本 ,免疫组织化学 ABC法染色 ,以正常羊血清代替一抗为阴性对照 ,TGFβ1 抗血清的工作浓度为 1:10 0 ,光镜观察。结果显示 TGFβ1 在人胚胎睾丸间质细胞呈阳性表达 ,曲细精管内精原细胞、支持细胞、管周肌样细胞未见阳性表达。TGFβ1 在 12周龄睾丸组织未见阳性表达 ,16周~ 32周均有阳性表达 ,在 16周时是表达的高峰 ,此后呈逐渐下降趋势 (P<0 .0 1)。由此结果表明TGFβ1 Immunohistochemical techniques of ABC were used to observe the expression of TGF β 1 in 30 testes of human fetus, whose gestational ages were estimated to be 12 to 32 weeks Normal goat serum was used to replace TGF β 1 in the negative control group The positive reaction of TGF β 1 was observed only in Leydig cells In the gestational age of 12 weeks, no positive reaction of TGF β 1 was observed In the gestational ages of 16 to 32 weeks, the positive reaction was present, and the peaks of TGF β 1 expression appeared in the gestational age of 16 weeks With the increase of gestational ages thereafter, the number of positive reaction cells decreased gradully ( P <0 01) This result suggests that TGF β 1 could play an important role during the development of human testis.
出处 《中国组织化学与细胞化学杂志》 CAS CSCD 2001年第4期403-405,472,共4页 Chinese Journal of Histochemistry and Cytochemistry
关键词 人睾丸 发生过程 TGFΒ1 表达 胚胎 免疫组织化学 TGF β 1 \ Testis \ Immunohistochemistry \ Fetus \ Human
  • 相关文献

参考文献2

  • 1孙卫民,细胞因子研究方法学,1999年,675页
  • 2刘斌,人体胚胎学,1995年,311页

同被引文献26

  • 1杨欣,丁彩飞,张永华,颜志中,杜静.菟丝子水提物对人精子膜结构和功能氧化损伤的干预作用[J].中国药学杂志,2006,41(7):515-518. 被引量:47
  • 2倪崖,陈文颖,李春波,袁玉英,毛伟,陈璋辉,石其贤.补肾强精颗粒剂的药效学研究[J].中国现代应用药学,2006,23(4):268-271. 被引量:7
  • 3闫永平,高婕,吕卫华.转化生长因子在睾丸中的表达研究进展[J].畜牧兽医杂志,2007,26(1):30-31. 被引量:8
  • 4董常生,闫永平,贺俊平,赫晓燕,任玉红,白瑞.转化生长因子-β1及其信号传导分子Smad2与Smad4在羊驼睾丸的表达[J].解剖学报,2007,38(4):481-485. 被引量:7
  • 5NETTERSHEIM D, GILLIS AJ, LOOIJENGA LH, et al. TGF-betal, EGF and FGF4 synergistically induce differentiation of the seminoma cell line TCam-2 into a cell type resembling mixed non-seminoma[J]. Int J Androl, 2011, 34(4) : 189-203.
  • 6GIANNELLI G, VILLA E, LAHN M. Transforming growth factor-beta as a therapeutic target in hepatocellular carcinoma [J]. Cancer Res, 2014,74(7) : 1890-1894.
  • 7ZARZYNSKA JM. Two faces of TGF-betal in breast cancer[J]. Mediators Inflamm, 2014, 2014: 141-747.
  • 8BI WR, YANG CQ, SHI Q. Transforming growth factor-beta1 induced epithelial-mesenchymal transition in hepatic fibrosisFJ]. Hepatogastroenterology, 2012,59(118) : 1960-1963.
  • 9SKEEN VR, PATERSON I, PARASKEVA C. TGF-betal sig- nalling, connecting aberrant inflammation and colorectal tumori- genesis[J]. Curr Pharm Des, 2012,18(26) : 3874-3888.
  • 10MORI S, KODARIRA M, ITO A, et al. Enhanced Expression of Integrin ave3 Induced by TGF-13 Is Required for the enhancing effect of fibroblast growth factor I(FGF1) in TGF-13-induced ep- ithe[ial-mesenchyma!, transition ( EMT ) in mammary epithelial cells[J]. PLoS One, 2015,9(10) : 1932-6203.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部